Home

Martin H. Huber Jr., President, CEO: Mersana Therapeutics MRSN Sell · Filed 25/09/15

Trade details

Type
Insider sale
Amount
$14,707.72
Shares · price
2,012 sh · $7.31 a share
Held after
9,572 sh
Trade date
25/09/12
Filed
25/09/15
Days to filing
3 days

Sold 17.4% of holdings

Share of holding sold
17.4%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/13~25/10/12

Martin H. Huber Jr.'s recent trades

  • Martin H. Huber Jr.

    BuySyndax Pharmaceuticals

    $45K

    Filed 25/05/19

  • Martin H. Huber Jr.

    Sell10b5-1 planMersana Therapeutics

    $2,618

    Filed 25/01/17

  • Martin H. Huber Jr.

    Sell10b5-1 planMersana Therapeutics

    $88.7K

    Filed 24/09/13

Martin H. Huber Jr., CEO — sold $14.7K of Mersana Therapeutics MRSN · 17.4% of holdings · 10b5-1 plan | Whalegun